Skip to main content
. 2019 Sep 22;25(2):e12702. doi: 10.1111/anec.12702

Table 3.

Adjusted regression coefficient and SE for individual predictors included in full model

  Regression coefficient, 95% CI p value
PVC burden %, (change from 4.0% to 17.4%) −0.644 (−1.063, −0.225) <.001
Antiarrhythmic drug use (yes:no) −0.287 (−0.723, 0.149) .091
PVC burden %a antiarrhythmic use .059
Interpolated PVC (yes:no) 0.070 (−0.223, 0.363) .640
Polymorphic PVCs (yes:no) −0.329 (−0.689, 0.030) .073
Sinus QRS duration, msn (change from 80 to 100) −0.031 (−0.227, 0.166) .068
PVC QRS duration, msn (change from 120 to 140) −0.191 (−0.529, 0.148) .049
PVC coupling interval, msn (change from 420 to 500) −0.201 (−0.546, 0.144) .632
Age, year (change from 38 to 60) −0.249 (−0.442, −0.056) .018
Gender (female:male) 0.116 (−0.144, 0.376) .381
LVOT origin (yes:no) 0.007 (−0.349, 0.364) .967
RVOT origin (yes:no) 0.072 (−0.253, 0.396) .665

Abbreviations: LVOT, left ventricular outflow tract; PVC, premature ventricular complex; RVOT; right ventricular outflow tract.

a

PVC burden % antiarrhythmic use interaction.